Funding Limits Will Force Choices At Device Evaluation Office – Tillman
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center says it will meet its fiscal year 2006 submission review time performance goals, but other activities might be neglected, given anticipated revenue
You may also be interested in...
Tillman Departs: Device Evaluation Director To Leave FDA March 26
Office of Device Evaluation Director Donna-Bea Tillman will step down March 26 to join Microsoft's health unit, she said in a March 1 email to her staff
Tillman Departs: Device Evaluation Director To Leave FDA March 26
Office of Device Evaluation Director Donna-Bea Tillman will step down March 26 to join Microsoft's health unit, she said in a March 1 email to her staff
MDUFMA Renewal Plan Spreads Fee Burden More Evenly; Senate Panel OKs
Just two days after FDA released its behind-schedule proposal to reauthorize the medical device user fee program, a Senate committee approved the agency's recommendations to collect almost $300 million from manufacturers through 2012